Role of mTOR inhibitor in cholangiocarcinoma cell progression

By        

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 854-860

Spandidos Publications

Access to resources Recommend Favorite

Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness

By                  

International Journal of Oncology, Vol. 47, Iss. 1, 2015-01 ,pp. : 398-410

Spandidos Publications

Access to resources Recommend Favorite

Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis

By Nakagawa Shigeki   Okabe Hirohisa   Sakamoto Yasuo   Hayashi Hiromitsu   Hashimoto Daisuke   Yokoyama Naomi   Sakamoto Keita   Kuroki Hideyuki   Mima Kosuke   Nitta Hidetoshi   Imai Katsunori   Chikamoto Akira   Watanabe Masayuki   Beppu Toru   Baba Hideo  

Annals of Surgical Oncology, Vol. 20, Iss. 3, 2013-12 ,pp. : 667-675

Springer Publishing Company

Access to resources Recommend Favorite

Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma

By Lin Cheng-Jui   Lim Ken-Hong   Cheng Yi-Chou   Chen Han-Hsiang   Wu Chih-Jen  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 455-457

Humana Press, Inc

Access to resources Recommend Favorite

Molecular mechanisms involved in the progression of myelodysplastic syndrome

By Nolte Florian   Hofmann Wolf-K  

Future Oncology, Vol. 6, Iss. 3, 2010-03 ,pp. : 445-455

Future Medicine

Access to resources Recommend Favorite